Commercialization: Page 75
-
PharmaVoice Team/PharmaVoice
Letter from the Editor
Publisher Lisa Banket Editor Taren Grom Creative Director Marah Walsh Managing EDitor Denise Myshko Senior EDitor Robin Robinson features EDitor Kim Ribbink Contributing Editor Carolyn Gretton design associate Ariel Medel national account manager Cathy Tracy CIRCULATION Assistant Kathy Deiuliis C...
By PharmaVoice Team • Dec. 28, 2009 -
PharmaVoice Team/PharmaVoice
The Year Ahead
Looking back to the varying changes and pressures the industry has endured, and ahead to how the industry will need to reinvent itself to continue to prosper, companies are adapting to longer-term marketplace trends and evolving patient needs. The industry is facing pressure from the economic, re...
By Denise Myshko and Robin Robinson • Nov. 10, 2009 -
PharmaVoice Team/PharmaVoice
Online Media: Will it Kill the Mass Media Stars?
Jeff Baker is President and CEO, Noble Marketing Group, a provider of PhRMA-compliant creative marketing solutions for pharmaceutical, biotechnology, and healthcare providers. For more information, visit gonoblerx.com. “There will be more focus on education versus branding, and because of the g...
By Robin Robinson • Nov. 10, 2009 -
PharmaVoice Team/PharmaVoice
Social Media
Arecent Manhattan Research report states that 88% of all physicians use the Internet to access pharmaceutical, biotech, and medical device information, and 41% of all the research that physicians conduct is now done online. Nielsen’s online data show that about half of the U.S. population visited...
By Robin Robinson • Nov. 10, 2009 -
PharmaVoice Team/PharmaVoice
The Salesforce of the Future
Our experts agree: the salesforce of the future will be more specialized, more technically advanced, and more clinically savvy; oh, and there will be fewer feet on the street, finally. If the past year is any indication, the salesforce of the future is going to experience an extreme makeover. For...
By PharmaVoice Team • Nov. 10, 2009 -
PharmaVoice Team/PharmaVoice
The Innovation Challenge
There has been a great deal of discussion related to the challenges hampering innovation to create differentiated medicines. Never before have research and cutting-edge science been more important to ensure a steady flow of innovation. Much has been made of the industry’s decline in R&D pro...
By PharmaVoice Team • Nov. 10, 2009 -
PharmaVoice Team/PharmaVoice
Reform, Consolidation, and Good Citizenry
Reform, Consolidation, and Good Citizenry Our experts featured in this issue identify healthcare reform, mergers and acquisitions, and corporate reputation as three of the many market changers that will impact how the industry does business in the future. Healthcare Reform: What’s to Come? The ye...
By Robin Robinson • Nov. 10, 2009 -
PharmaVoice Team/PharmaVoice
The Crystal Ball
We asked our readers to identify the top trends and market shapers they expect to define the various industry sectors in the coming year. Some of their responses may already be on your radar, while others may provide a new and different perspective. There’s little doubt that 2010 will be another...
By PharmaVoice Team • Nov. 10, 2009 -
PharmaVoice Team/PharmaVoice
On the Calendar
November 16-17 Pharmaceutical Coverage & Reimbursement Conference Washington, D.C. Q1 Productions, q1productions.com November 16-17 The 3rd Pediatric Clinical Trials Grand Hyatt Washington, Washington, D.C. ExL Pharma, exlpharma.com November 17-18, 2009 13th Advanced Forum on Structuring, Neg...
By PharmaVoice Team • Nov. 9, 2009 -
PharmaVoice Team/PharmaVoice
Index
Julian Adams, Ph.D. President, Research and Development and Chief Scientific Officer, Infinity Pharmaceuticals Inc. Brent Ahrens. General Partner, Canaan Partners Kenneth C. Aldrich. CEO, Chairman, and Co-Founder, International Stem Cell Corp. Meryl Allison. Principal, Deloitte Consulting Karl...
By PharmaVoice Team • Nov. 9, 2009 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Service Consolidation Recommended for Clinical trial Offices Emerging centralized clinical trial offices (CTOs) are among the newest developments within the research administration infrastructure of academic health centers. Little uniformity exists in the structure or functions of existing CTOs, ...
By PharmaVoice Team • Nov. 9, 2009 -
PharmaVoice Team/PharmaVoice
E-Media
IMS Health’s Ask IMS is a cost-effective, Web-based service that provides strategic market intelligence to help drive the growth and success of early-stage biopharmaceutical companies. Drawn from IMS’ comprehensive pharmaceutical market information, Ask IMS offers timely decision-making support f...
By PharmaVoice Team • Nov. 9, 2009 -
PharmaVoice Team/PharmaVoice
What's New
inVentiv Health’s recently launched risk evaluation and mitigation strategy (REMS) offering provides pharmaceutical and biotechnology clients with a customizable suite of REMS-related services that can be delivered through a single, integrated program. In an effort to assure safe use of prescript...
By PharmaVoice Team • Nov. 9, 2009 -
PharmaVoice Team/PharmaVoice
UpFront
In Memoriam Linda Ley Ciccarelli Linda Ciccarelli, VP and senior director of media services at Sudler & Hennessey, passed away on Sunday, Sept. 27, 2009, at her home in Wakefield, R.I. A founding member of the Association of Healthcare Media Directors (AHMD), Ms. Ciccarelli was a longtime lea...
By PharmaVoice Team • Nov. 9, 2009 -
PharmaVoice Team/PharmaVoice
For Art's Sake
CREATIVE review The mind often plays tricks on the memory. I’ve kept a fading mental picture of this outstand ing ad for years, and now that I’ve seen it again my recollection has been indelibly altered.The headline type size isn’t as small as I remembered. There’s more body copy than I recalled ...
By PharmaVoice Team • Nov. 9, 2009 -
PharmaVoice Team/PharmaVoice
Pharma Outlet
Sy Syms, founder of the offprice designer clothing chain that carries his name, loves to say that “an educated consumer is our best customer.” In fact, he loves the concept so much he registered the phrase “educated consumer” as a company trademark. But that doesn’t mean Sy has a patent on using ...
By Jack Trout • Nov. 9, 2009 -
PharmaVoice Team/PharmaVoice
What's on your mind: Opinions
A “Free Economy?” I, for one, am getting sick and tired of the Federal Government interfering with what we used to refer to as the “Free Economy.” Capi talism doesn’t work if there is interference from outside organizations. When there are rules placed on competitors in a free economy, benefiting...
By PharmaVoice Team • Nov. 9, 2009 -
PharmaVoice Team/PharmaVoice
Raise Your Voice: Letters
Worth the price of admission For years, economic developers have flocked in droves to the semiannual World Congress of the International Development Research Council (IDRC, now CoreNet). But if the recent BIO 2002 conference in Toronto is any barometer, the International Biotechnology Convention ...
By PharmaVoice Team • Nov. 9, 2009 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh DIRECTOR OF SALES Darlene Kwiatkowski CONTRIBUTING EDITORS Virginia Kirk Denise Myshko Elisabeth Pena Kim Ribbink Alex Robinson Lynda Sears Copyright 2002 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume Two, Numb...
By Taren Grom • Nov. 9, 2009 -
PharmaVoice Team/PharmaVoice
CRM: Connecting the Dots...
CUSTOMER RELATIONSHIP MANAGEMENT BY TAREN GROM CRM requires a multilevel, enterprisewide view of customers — thereby demanding a strong customer data management business practice . A 5% increase in customer retention can lead to a 25% to 85% profit increase,depending on the industry. — HarvardBus...
By PharmaVoice Team • Nov. 4, 2009 -
PharmaVoice Team/PharmaVoice
Swimming the Channels
Think back 15 years and consider how much simpler the role of marketing a brand was. There were a few solid, inescapable channels to choose from to reach an audience. Printed materials, such as direct mail and collateral, were a mainstay of many marketing efforts; television or radio provided a m...
By PharmaVoice Team • Nov. 4, 2009 -
PharmaVoice Team/PharmaVoice
PharmaTrax
buster brands,”says David Lipson,forecasting practice leader at IMS Global Consulting.“But we are not see ing the avalanche that some feared. Although the number of major new product launches was smaller than usual last year, the genuine value provided by medicines introduced over the past dozen ...
By PharmaVoice Team • Nov. 3, 2009 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review Let’s face it — physicians don’t see erosive GERD as lifethreatening or the relief of heartburn as rocket science. So it’s entirely appropriate to take a lighthearted approach to promote Protonix, the proton pump inhibitor from Wyeth. And because GERD is an ailment that most often...
By PharmaVoice Team • Nov. 3, 2009 -
PharmaVoice Team/PharmaVoice
What's on your mind: Opinions
Digital Docs Albert Einstein said, “I never think of the future, it comes too quickly.” This is true for most of the doctors in Amer ica. According to the latest research from PERQ/HCI Media, 30% of doctors have PDAs, and that is expected to double over the next cou ple years. Therefore, we have ...
By PharmaVoice Team • Nov. 2, 2009 -
PharmaVoice Team/PharmaVoice
Raise Your Voice: Letters
An Important Frontier Kudos to the PharmaVOICE team for having brought together a very useful forum on the topic of diversity and multicultural market development for the pharma industry. I received many calls from the industry, and the topic and the theme is definitely going to be an important f...
By PharmaVoice Team • Nov. 2, 2009
Previous
